Abu Dhabi National Energy Co PJSC
22 October 2026
Abu Dhabi National Energy Company PJSC
Publication of Final Terms
The following final terms (the Final Terms) are available for viewing:
1. Final Terms in relation to the issue of U.S.$1,100,000,000 5.875 per cent. Green Notes due 2032 by the Abu Dhabi National Energy Company PJSC (the Issuer) under the Issuer's U.S.$20,000,000,000 Global Medium Term Note Programme (the Programme)
2. Final Terms in relation to the issue of U.S.$650,000,000 6.125 per cent. Notes due 2036 by the Issuer under the Programme
To view the full document, please paste the following URL into the address bar of your browser.
http://www.rns-pdf.londonstockexchange.com/rns/1154A_1-2026-10-22.pdf
http://www.rns-pdf.londonstockexchange.com/rns/1154A_2-2026-10-22.pdf
A copy of the Final Terms will shortly be available for inspection at: https://data.fca.org.uk/#/nsm/nationalstoragemechanism.
For further information, please contact ir@taqa.com and treasury@taqa.com
Abu Dhabi National Energy Company PJSC
Level 25, Al Maqam Tower
ADGM Square, Al Maryah Island
P.O. Box 55224, Abu Dhabi
United Arab Emirates
Telephone: +971 2 691 4900
DISCLAIMER - INTENDED ADDRESSEES
The Final Terms referred to above must be read in conjunction with the base prospectus dated 1 May 2026, as supplemented by the supplements dated 6 July 2026 and 15 September 2026 in respect of the Programme (together, the Base Prospectus) for the purposes of the Prospectus Rules: Admission to Trading on a Regulated Market sourcebook.
Please note that the information contained in the Base Prospectus and the Final Terms may be addressed to and/or targeted at persons who are residents of particular countries (specified in the Final Terms and/or the Base Prospectus) only and is not intended for use and should not be relied upon by any person outside these countries and/or to whom the offer contained in the Final Terms and/or the Base Prospectus is not addressed. Prior to relying on the information contained in the Final Terms and the Base Prospectus you must ascertain from the Final Terms and the Base Prospectus whether or not you are part of the intended addressees of the information contained therein.
This publication does not constitute an offering of securities for sale in the United States. The securities discussed herein have not been and will not be registered under the United States Securities Act of 1933, as amended (the Securities Act) or with any securities regulatory authority of any state or other jurisdiction of the United States, and the securities may not be offered or sold in the United States of America or to, or for the account or benefit of, U.S. persons (as defined in the Securities Act), absent registration or an exemption from registration under the Securities Act. No public offering of securities is being or will be made in the United States of America.
The Final Terms has been made available to you in an electronic form. You are reminded that documents transmitted via this medium may be altered or changed during the process of electronic transmission and consequently none of the Issuer, its advisers nor any person who controls any of them nor any director, officer, employee nor agent of it or affiliate of any such person accepts any liability or responsibility whatsoever in respect of any difference between the Final Terms made available to you in electronic format and the hard copy version available to you on request from the Issuer.
Your right to access this service is conditional upon complying with the above requirement.
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
ENDRNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.